DigiStain

We Save Patients From Avoidable Chemotherapy

Digistain

We Save Patients From Avoidable Chemotherapy
 

50% of women with breast cancer suffer through expensive and potentially lethal chemotherapy they don’t need. Digistain solves this problem by scanning biopsies in the infrared to measure the increase in cancerous DNA. We remove the guesswork from diagnosis

 

 

Supported by:

Subscribe to leading news and insights

To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.